ProphetesAI is thinking...
relapsed
MindMap
Loading...
Sources
relapsed
relapsed, ppl. a. (rɪˈlæpst) [f. prec. + -ed1.] Fallen back into a previous condition.1570 Foxe A. & M. (ed. 2) 943/1 Asked..why he should not..be pronounced a relapsed hereticke. 1607 Topsell Four-f. Beasts (1658) 145 They..recover for a small time, and then fall into a relapsed malady. 1683 Apol. ...
Oxford English Dictionary
prophetes.ai
Matthew Perry's ex saw signs he had relapsed… thoughts?
Matthew Perry's ex saw signs he had relapsed… thoughts? TRIGGER WARNING. Overview- the Matt man thing- apparently did it when he wasn't sober.
www.reddit.com
www.reddit.com
Matthew Perry's Ex-Girlfriend Claimed He Relapsed Before ...
Apr 26, 2024 — Matthew Perry's Ex-Girlfriend Claimed He Relapsed Before Death: He Was 'Mattman' When He Wasn't Sober ... Matthew Perry's ex-girlfriend Kayti ...
www.inquisitr.com
Blinatumomab retreatment after relapse in patients with relapsed ...
Relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) is an aggressive malignant disease with poor prognosis and an unmet medical need.
www.nature.com
[Observation of liver indexes in patients with relapsed/refractory ...
Oct 1, 2023Europe PMC is an archive of life sciences journal literature.
europepmc.org
[Observation of liver indexes in patients with relapsed/refractory ...
Oct 14, 2023Objective: To observe the characteristics of the evolution of liver indexes in patients with relapsed/refractory multiple myeloma (RRMM) treated with CAR-T-cells based on BCMA.Methods: Retrospective analysis was performed of patients with RRMM who received an infusion of anti-BCMA CAR-T-cells and anti-BCMA combined with anti-CD19 CAR-T-cells at our center between June 1, 2019, and February 28 ...
pubmed.ncbi.nlm.nih.gov
FDA Grants Priority Review to Odronextamab in Relapsed/Refractory ...
Sep 29, 2023FDA. The FDA has granted priority review to the biologics license application (BLA) seeking the approval of odronextamab (REGN1979) for the treatment of adult patients with relapsed/refractory ...
www.onclive.com
复发性或难治性滤泡淋巴瘤的治疗 - UpToDate
本文将讨论复发性或难治性fl的治疗。fl的初始治疗(包括随诊观察后治疗)、流行病学、临床表现、病理特征、诊断和病理生物学详见其他专题。 (参见 "Ⅱ-Ⅳ期滤泡淋巴瘤的初始治疗") (参见 "Ⅰ期滤泡淋巴瘤的初始治疗")
www.uptodate.com
[Durable molecular remission in a patient with relapsed NPM1/IDH1 ...
Feb 1, 20222019年6月14日（Ven+AZA开始治疗后第42天）骨髓象：增生活跃，原始粒细胞1.5％。免疫残留：阴性。NPM1阴性，提示骨髓获得第2次CR（CR 2 ），NPM1水平转阴。2019年6月20日给予患者Ven（Venclyxto，AbbVie Türkiye公司产品）200 mg口服28 d，间隔28 d进行维持治疗，监测骨髓持续CR ...
europepmc.org
[Outcomes of refractory or relapsed DNMT3A - Europe PMC
Europe PMC is an archive of life sciences journal literature. https://orcid.org
europepmc.org
[Chimeric antigen receptors T cells in treatment of a relapsed ...
病例资料. 患儿，女，11岁。2010年12月15日以"间断发热10余天，骶尾部及颈部疼痛10 d"起病，于当地医院就诊，当时查体：肝肋缘下3 cm，脾肋缘下4 cm；血常规：wbc 8.89 × 10 9 /l，hgb 109 g/l，plt 69 × 10 9 /l；骨髓象：原幼淋巴细胞0.895，符合all-l 2 ；免疫分型：b淋系表达；染色体核型：46，xx；融合基因 ...
europepmc.org
[Outcomes of refractory or relapsed DNMT3A - Europe PMC
Europe PMC is an archive of life sciences journal literature. https://orcid.org
europepmc.org
[A clinical study of IGEV regimen in the treatment of relapsed and ...
注：abvd方案：表柔比星+博莱霉素+长春地辛+达卡巴嗪；b症状：发热、盗汗、体重减轻；igev方案：异环磷酰胺+吉西他滨+长春瑞滨+泼尼松；ice方案：异环磷酰胺+卡铂+依托泊苷；beacopp方案：博莱霉素+表柔比星+依托泊苷+环磷酰胺+长春地辛+丙卡巴肼+泼尼松； a 行 ...
europepmc.org
[Chimeric antigen receptors T cells in treatment of a relapsed ...
病例资料. 患儿，女，11岁。2010年12月15日以"间断发热10余天，骶尾部及颈部疼痛10 d"起病，于当地医院就诊，当时查体：肝肋缘下3 cm，脾肋缘下4 cm；血常规：wbc 8.89 × 10 9 /l，hgb 109 g/l，plt 69 × 10 9 /l；骨髓象：原幼淋巴细胞0.895，符合all-l 2 ；免疫分型：b淋系表达；染色体核型：46，xx；融合基因 ...
europepmc.org
[Outcomes of refractory or relapsed DNMT3A - Europe PMC
Results. The median age of DNMT3A + AML patients was 46 years old, higher white blood cells and bone marrow blasts were observed in DNMT3A + AML group. The ORR and complete response (CR) rate of DNMT3A + group were 62.50% and 54.17%, respectively. No differences were observed in ORR and CR rates (P>0.05) between these two groups.DNMT3A + /FLT3-ITD + CN-AML patients (n=14) had higher ORR and CR ...
europepmc.org